DNA methylation biomarkers for hepatocellular carcinoma

BACKGROUND: Aberrant methylation of DNA is a key driver of hepatocellular carcinoma (HCC). In this study, we sought to integrate four cohorts profile datasets to identify such abnormally methylated genes and pathways associated with HCC. METHODS: To this end, we downloaded microarray datasets examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Guorun, Tu, Yaqin, Chen, Cai, Sun, Haiying, Wan, Chidan, Cai, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142709/
https://www.ncbi.nlm.nih.gov/pubmed/30245591
http://dx.doi.org/10.1186/s12935-018-0629-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142709/
https://www.ncbi.nlm.nih.gov/pubmed/30245591
http://dx.doi.org/10.1186/s12935-018-0629-5

Ejemplares similares